MC-Val-Cit-PAB-Amide-TLR7 agonist 4
This conjugate, formed by linking the MC-Val-Cit-PAB-Amide linker to a TLR7 agonist, is a research tool for developing antibody-drug conjugates (ADCs) . It is utilized in cancer research to investigate targeted immunostimulatory therapies in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2413016-49-4
Product Name Alternative
MC-Val-Cit-PAB-Amide-TLR7 agonist 4
Field of Research
Cardiovascular Research, Immunology & Inflammation, Pharmacology & Drug Discovery; Cell Biology, Signal Transduction
Purity
97.70% (May vary between batches)
Smiles
C (C (OCCNC (C (NC (OCC1=CC=C (NC ([C@@H] (NC ([C@@H] (NC (CCCCCN2C (=O) C=CC2=O) =O) [C@@H] (C) C) =O) CCCNC (N) =O) =O) C=C1) =O) (C) C) =O) (C) C) N3C4=C (N=C3COCC) C (N) =NC=5C4=CC=CC5
Molecular Formula
C52H72N12O11
Molecular Weight
1041.2
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680828-500 1x 500 µL
CD79a (JCB117 + HM47/A9), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402312-500 1x 500 µL
SOX10 (Melanoma Marker) (rSOX10/1074), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 